Relmada Therapeutics (RLMD) Stock Chart & Stock Price History $0.29 +0.01 (+4.98%) Closing price 03/7/2025 04:00 PM EasternExtended Trading$0.28 -0.01 (-3.66%) As of 03/7/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Relmada Therapeutics Stock Price Performance 5 Day Performance+8.98%1 Month Performance-7.31%3 Month Performance-40.44%6 Month Performance-89.73%Year-To-Date Performance-44.90%1 Year Performance-95.49% Receive RLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Remove Ads RLMD Stock Chart for Sunday, March, 9, 2025 RLMD Chart by TradingViewRemove Ads Relmada Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/07/2025$0.27$0.29+4.98%$0.29$0.26524,610 shs$8.65 million03/06/2025$0.26$0.27+5.33%$0.27$0.25359,032 shs$8.23 million03/05/2025$0.26$0.26-1.45%$0.27$0.26275,114 shs$7.82 million03/04/2025$0.26$0.26+3.10%$0.26$0.24470,019 shs$7.93 million03/03/2025$0.26$0.26-1.92%$0.26$0.24447,207 shs$7.69 million02/28/2025$0.28$0.26-5.76%$0.28$0.26337,027 shs$7.85 million02/27/2025$0.27$0.28+2.19%$0.28$0.26379,561 shs$8.33 million02/26/2025$0.28$0.27-3.50%$0.29$0.26254,851 shs$8.15 million02/25/2025$0.29$0.28-2.00%$0.29$0.26323,616 shs$8.44 million02/24/2025$0.30$0.29-3.22%$0.29$0.28414,120 shs$8.61 million Get the Latest News and Ratings for RLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/21/2025$0.31$0.30-6.05%$0.32$0.29763,148 shs$8.90 million02/20/2025$0.33$0.31-4.27%$0.33$0.31534,288 shs$9.47 million02/19/2025$0.33$0.33-1.06%$0.34$0.31444,040 shs$9.90 million02/18/2025$0.33$0.33-0.42%$0.35$0.32693,350 shs$10.00 million02/17/2025$0.33$0.33$0.36$0.311.27 million shs$10.04 million02/14/2025$0.33$0.33+1.31%$0.36$0.311.27 million shs$10.04 million02/13/2025$0.30$0.33+7.77%$0.35$0.291.27 million shs$9.91 million02/12/2025$0.29$0.30+6.68%$0.31$0.28666,972 shs$9.20 million02/11/2025$0.31$0.29-7.33%$0.30$0.28945,792 shs$8.62 million02/10/2025$0.31$0.31-0.23%$0.31$0.291.25 million shs$9.30 million Related Companies Opus Genetics Stock Price Chart iBio Stock Price Chart Synergy CHC Corp. (Uplisting) Stock Price Chart Coeptis Therapeutics Stock Price Chart Passage Bio Stock Price Chart Pluri Stock Price Chart Verrica Pharmaceuticals Stock Price Chart Grace Therapeutics Stock Price Chart Rallybio Stock Price Chart Q32 Bio Stock Price Chart Receive RLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RLMD) was last updated on 3/9/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relmada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RLMD Stock Alerts